- Corporate Officers - S
- Spiegelman Daniel K
Insider Trading History of Spiegelman Daniel K
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Spiegelman Daniel K since 2006.
This trader's CIK number is 1238403.
At the time of last reporting, Spiegelman Daniel K was the Director of Myriad Genetics Inc. (stock ticker symbol MYGN).
Also see all insider trading activities at Myriad Genetics Inc.
Note that in the past
SPIEGELMAN DANIEL K also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Biomarin Pharmaceutical Inc (BMRN) by Spiegelman Daniel K
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | BMRN | 0 | $0 | 13,573 | $1,208,097 | 0 | $0 |
| 2018 | BMRN | 0 | $0 | 21,059 | $1,898,546 | 0 | $0 |
| 2017 | BMRN | 0 | $0 | 44,292 | $4,140,323 | 30,000 | $1,893,000 |
| 2016 | BMRN | 0 | $0 | 54,882 | $4,951,730 | 16,896 | $659,957 |
| 2015 | BMRN | 0 | $0 | 78,850 | $9,324,901 | 35,500 | $1,386,630 |
| 2014 | BMRN | 0 | $0 | 28,458 | $2,040,147 | 24,000 | $937,440 |
| 2013 | BMRN | 0 | $0 | 50,066 | $3,299,230 | 46,000 | $1,796,760 |
Yearly summary of insider trading at Relypsa Inc (RLYP) by Spiegelman Daniel K
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | RLYP | 0 | $0 | 1,013 | $19,562 | 0 | $0 |
Yearly summary of insider trading at Cascadian Therapeutics, Inc. (CASC) by Spiegelman Daniel K
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | CASC | 0 | $0 | 0 | $0 | 13,581 | $0 |
| 2015 | CASC | 20,000 | $32,130 | 0 | $0 | 16,042 | $0 |
| 2013 | CASC | 0 | $0 | 16,183 | $30,901 | 19,352 | $0 |
| 2011 | CASC | 0 | $0 | 0 | $0 | 2,076 | $0 |
Yearly summary of insider trading at Myriad Genetics Inc (MYGN) by Spiegelman Daniel K
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | MYGN | 0 | $0 | 8,638 | $198,760 | 0 | $0 |
| 2022 | MYGN | 0 | $0 | 6,424 | $123,674 | 0 | $0 |
| 2021 | MYGN | 0 | $0 | 10,281 | $302,821 | 0 | $0 |
Yearly summary of insider trading at Cv Therapeutics Inc (CVTX) by Spiegelman Daniel K
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | CVTX | 0 | $0 | 141,029 | $2,807,887 | 201,457 | $2,521,373 |
| 2008 | CVTX | 0 | $0 | 0 | $0 | 14,688 | $122,531 |
| 2007 | CVTX | 0 | $0 | 21,000 | $237,750 | 12,732 | $0 |
| 2006 | CVTX | 0 | $0 | 3,000 | $38,760 | 5,121 | $0 |
Insider trading activities at 5 companies by Spiegelman Daniel K:
1. Biomarin Pharmaceutical Inc (BMRN)
2. Relypsa Inc (RLYP)
3. Cascadian Therapeutics, Inc. (CASC)
4. Myriad Genetics Inc (MYGN)
5. Cv Therapeutics Inc (CVTX)
Table 1. Insider trading of Biomarin Pharmaceutical Inc (BMRN) by Spiegelman Daniel K
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-04-01 | BMRN | Sale | 13,473 | 89.00 | 1,199,097 |
| 2019-03-27 | BMRN | Sale | 100 | 90.00 | 9,000 |
| 2018-06-22 | BMRN | Sale | 10,000 | 99.00 | 990,050 |
| 2018-04-23 | BMRN | Sale | 11,059 | 82.15 | 908,496 |
| 2017-03-16 | BMRN | Sale | 1,989 | 91.96 | 182,908 |
| 2017-03-06 | BMRN | Sale | 2,303 | 93.32 | 214,915 |
| 2017-02-28 | BMRN | Option Ex | 30,000 | 63.10 | 1,893,000 |
| 2017-02-28 | BMRN | Sale | 30,000 | 94.00 | 2,820,000 |
| 2017-03-01 | BMRN | Sale | 5,000 | 94.50 | 472,500 |
| 2017-01-09 | BMRN | Sale | 5,000 | 90.00 | 450,000 |
| 2016-11-09 | BMRN | Sale | 20,000 | 90.61 | 1,812,200 |
| 2016-08-01 | BMRN | Sale | 4,000 | 99.33 | 397,320 |
| 2016-06-06 | BMRN | Sale | 1,649 | 89.14 | 146,991 |
| 2016-05-31 | BMRN | Option Ex | 16,896 | 39.06 | 659,957 |
| 2016-05-31 | BMRN | Sale | 20,841 | 89.67 | 1,868,916 |
| 2016-05-23 | BMRN | Sale | 3,769 | 87.08 | 328,185 |
| 2016-03-02 | BMRN | Sale | 4,623 | 86.12 | 398,118 |
| 2015-11-16 | BMRN | Option Ex | 20,000 | 39.06 | 781,200 |
| 2015-11-16 | BMRN | Sale | 20,000 | 104.30 | 2,085,920 |
| 2015-06-05 | BMRN | Sale | 1,649 | 122.30 | 201,669 |
| 2015-06-01 | BMRN | Sale | 3,945 | 124.16 | 489,811 |
| 2015-05-29 | BMRN | Sale | 1,578 | 126.15 | 199,064 |
| 2015-05-18 | BMRN | Sale | 34,078 | 130.00 | 4,430,140 |
| 2015-05-18 | BMRN | Sale | 2,059 | 124.77 | 256,905 |
| 2015-03-02 | BMRN | Option Ex | 15,500 | 39.06 | 605,430 |
| 2015-03-02 | BMRN | Sale | 15,500 | 107.00 | 1,658,500 |
| 2014-05-02 | BMRN | Sale | 11 | 58.40 | 642 |
| 2014-09-03 | BMRN | Sale | 18 | 69.77 | 1,255 |
| 2014-03-05 | BMRN | Sale | 12 | 82.93 | 995 |
| 2014-09-02 | BMRN | Sale | 16,000 | 69.83 | 1,117,312 |
| 2014-09-02 | BMRN | Option Ex | 16,000 | 39.06 | 624,960 |
| 2014-08-01 | BMRN | Sale | 2,229 | 61.76 | 137,651 |
| 2014-07-02 | BMRN | Sale | 2,229 | 64.00 | 142,656 |
| 2014-03-03 | BMRN | Option Ex | 8,000 | 39.06 | 312,480 |
| 2014-03-03 | BMRN | Sale | 8,000 | 80.32 | 642,528 |
| 2013-12-02 | BMRN | Option Ex | 9,000 | 39.06 | 351,540 |
| 2013-12-02 | BMRN | Sale | 9,000 | 70.14 | 631,269 |
| 2013-09-04 | BMRN | Sale | 9,000 | 69.00 | 621,000 |
| 2013-09-04 | BMRN | Option Ex | 9,000 | 39.06 | 351,540 |
| 2013-07-01 | BMRN | Sale | 4,066 | 59.78 | 243,061 |
| 2013-05-01 | BMRN | Sale | 28,000 | 64.42 | 1,803,900 |
| 2013-05-01 | BMRN | Option Ex | 28,000 | 39.06 | 1,093,680 |
Table 2. Insider trading of Relypsa Inc (RLYP) by Spiegelman Daniel K
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-06-07 | RLYP | Sale | 1,013 | 19.31 | 19,562 |
Table 3. Insider trading of Cascadian Therapeutics, Inc. (CASC) by Spiegelman Daniel K
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-09-24 | CASC | Option Ex | 2,375 | .00 | 0 |
| 2017-06-24 | CASC | Option Ex | 9,058 | .00 | 0 |
| 2017-06-12 | CASC | Option Ex | 2,148 | .00 | 0 |
| 2015-06-13 | ONTY | Option Ex | 16,042 | .00 | 0 |
| 2015-03-25 | ONTY | Buy | 10,000 | 1.63 | 16,270 |
| 2015-03-26 | ONTY | Buy | 10,000 | 1.59 | 15,860 |
| 2013-07-10 | ONTY | Sale | 3,403 | 1.72 | 5,853 |
| 2013-02-20 | ONTY | Sale | 12,780 | 1.96 | 25,048 |
| 2014-03-11 | ONTY | Option Ex | 19,352 | .00 | 0 |
| 2011-06-12 | ONTY | Option Ex | 2,076 | .00 | 0 |
Table 4. Insider trading of Myriad Genetics Inc (MYGN) by Spiegelman Daniel K
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-06-02 | MYGN | Sale | 8,638 | 23.01 | 198,760 |
| 2022-06-06 | MYGN | Sale | 6,424 | 19.25 | 123,674 |
| 2021-06-17 | MYGN | Sale | 3,139 | 30.52 | 95,796 |
| 2021-05-28 | MYGN | Sale | 7,142 | 28.99 | 207,025 |
Table 5. Insider trading of Cv Therapeutics Inc (CVTX) by Spiegelman Daniel K
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-04-02 | CVTX | Option Ex | 188,958 | 12.31 | 2,326,639 |
| 2009-04-02 | CVTX | Sale | 141,029 | 19.91 | 2,807,887 |
| 2009-02-25 | CVTX | Option Ex | 12,499 | 15.58 | 194,734 |
| 2008-12-11 | CVTX | Option Ex | 5,000 | 8.48 | 42,400 |
| 2008-12-09 | CVTX | Option Ex | 5,000 | 9.51 | 47,550 |
| 2008-02-26 | CVTX | Option Ex | 4,688 | 6.95 | 32,581 |
| 2007-12-21 | CVTX | Sale | 6,000 | 10.00 | 60,000 |
| 2007-12-10 | CVTX | Sale | 8,000 | 10.03 | 80,240 |
| 2007-01-17 | CVTX | Sale | 7,000 | 13.93 | 97,510 |
| 2007-01-03 | CVTX | Option Ex | 12,732 | .00 | 0 |
| 2006-12-12 | CVTX | Sale | 3,000 | 12.92 | 38,760 |
| 2006-12-05 | CVTX | Option Ex | 5,000 | .00 | 0 |
| 2006-01-03 | CVTX | Option Ex | 121 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Spiegelman Daniel K
(Director of Myriad Genetics Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.